Lewis, M M <br/><br/>
D1 and functionally selective dopamine agonists as neuroprotective agents in Parkinson's disease.  [electronic resource] 

 -  CNS & neurological disorders drug targets  Jun 2006 
 - 345-53 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1871-5273 
<br/><br/><label>Standard No.: </label>10.2174/187152706777452245  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Dopamine Agonists--chemistry<br/>Humans<br/>Neuroprotective Agents--pharmacology<br/>Parkinson Disease--physiopathology<br/>Receptors, Dopamine D1--agonists